FDA Enforcement Powers Remain In Limbo As User Fee Bill Glides Through Markup

Senate committee approves comprehensive user fee bill, but FDA authority to destroy some unsafe drug imports and track-and-trace provisions remain outstanding issues. Meanwhile, the House is going back to the drawing board on several provisions.